By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Provectus Biopharmaceuticals Inc. 

7327 Oak Ridge Highway
Suite B
Knoxville  Tennessee  37931  U.S.A.
Phone: 866-594-5999 Fax:


Company News
Provectus Announces Terms Of Definitive Financing Commitment 3/24/2017 10:39:48 AM
Provectus Enters Into Definitive Financing Commitment Term Sheet 3/20/2017 9:57:53 AM
Provectus Announces Extension Of Rights Offering Due To Receipt Of Unsolicited Investment Proposals To Invest In Provectus 3/6/2017 8:17:55 AM
Provectus Provides Information On Rights Offering Deadline 2/24/2017 8:11:29 AM
Provectus Appoints Bruce Horowitz And Dominic Rodrigues As Special Advisers To The Board Of Directors 2/23/2017 7:49:14 AM
Provectus Announces Extension Of Rights Offering 2/13/2017 6:49:59 AM
Provectus Announces Commencement Of Rights Offering To Existing Stockholders And Holders Of Certain Warrants 1/31/2017 8:13:54 AM
Provectus Fires Peter Culpepper as Interim CEO and COO 12/29/2016 6:45:41 AM
Provectus Announces Two Poster Presentations On PV-10 For Liver Tumors 12/22/2016 1:53:59 PM
Provectus Announces Agreement With POETIC (Pediatric Oncology Experimental Therapeutics Investigators Consortium) To Study Potential Of PV-10 For Pediatric Cancer 12/8/2016 12:56:11 PM